Exploiting the Body's Immune System to Treat a Broad Range of Diseases

ARMO in the News

05/10/18 — Lilly Announces Agreement To Acquire ARMO BioSciences  Read more

04/25/18 — ARMO BioSciences Announces Poster Presentations of Pegilodecakin (AM0010) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting  Read more

04/03/18 — ARMO BioSciences to Participate in Panel on Cytokines at 8th Annual Cancer Immunotherapy Conference  Read more